David Bartlett, MD
Surgical Oncology · Pittsburgh, PANPI 1952373862
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,637 of the $2,306 with a category attached, or 71.0%. Illumina, Inc. accounts for 71.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $1,903 and has fallen 94.3% since, to $109 in 2024.
Across 10 payments — averaging $230.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Illumina, Inc.$2K
- Elekta, Inc.$202
- Intera Oncology, Inc$154
- Intuitive Surgical$130
- Olympus America Inc.$109
- E.r. Squibb & Sons, L.L.C.$53
- plus $22 from 1 others
Across 1 payment — averaging $60,600 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Iovance Biotherapeutics, Inc.$61K
What the payments were for
- Speaking & faculty fees$1,63771%
- Food & beverage$66929%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Illumina, Inc. | 2 | $1,637 |
| Elekta, Inc. | 2 | $202 |
| Intera Oncology, Inc | 1 | $154 |
| Intuitive Surgical | 1 | $130 |
| Olympus America Inc. | 2 | $109 |
| E.r. Squibb & Sons, L.L.C. | 1 | $53 |
| Johnson & Johnson | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oncology Testing$1,637
- ELEKTA MEDICAL LINEAR ACCELERATOR$545
- Intera 3000 Hepatic Artery Infusion Pump$154
- Clarity$136
- Da Vinci Surgical System$130
How this compares
$2,306 in reported general payments places this provider in the 60th percentile of 78 surgical oncology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Pittsburgh
- Matthew HoltzmanPittsburgh$11K
- Amer ZureikatPittsburgh$9K
- Suzanne SchiffmanPittsburgh$7K
- Norman WolmarkPittsburgh$7K
- Quratulain SabihPittsburgh$5K
- Marc BrozovichPittsburgh$5K
- Victoria KimPittsburgh$3K
- Emilia DiegoPittsburgh$1K
- Andrew WatsonPittsburgh$868
- Gina IacoboniPittsburgh$685
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.